Page last updated: 2024-09-03

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Hypertension, Pulmonary

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with Hypertension, Pulmonary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lefferts, PL; Lu, W; Snapper, JR; Thabes, JS1
Franco-Cereceda, A; Holm, P; Liska, J1

Other Studies

2 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Hypertension, Pulmonary

ArticleYear
Role of endothelin in endotoxin-induced sustained pulmonary hypertension in sheep.
    American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:1

    Topics: Animals; Antihypertensive Agents; Dansyl Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Endothelins; Endotoxemia; Female; Hypertension, Pulmonary; Lymph; Male; Premedication; Pulmonary Wedge Pressure; Sheep; Thromboxane B2

1998
The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.
    Cardiovascular research, 1998, Volume: 37, Issue:3

    Topics: Animals; Antihypertensive Agents; Dansyl Compounds; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Nitric Oxide Synthase; Nitroarginine; Pulmonary Artery; Swine

1998